Physician profile
Thomas Duckett
NPI 1790700532
$539.57
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.04 · 2020: $80.33 · 2021: $21.60 · 2023: $203 · 2024: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $381.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $117.55 | 2020-2023 | Itind System, Soltive, Evis Exera III Video System Center |
| Pfizer INC. | $109.84 | 2024 | |
| Sumitomo Pharma America, INC. | $96.11 | 2023 | Gemtesa |
| 180 Medical, INC. | $68.98 | 2024 | Cure Ultra Catheter |
| Astellas Pharma US INC | $30.03 | 2023 | Myrbetriq |
| Dentsply Ih Ab | $23.87 | 2023 | Lofric |
| Endo Pharmaceuticals INC. | $22.86 | 2019 | |
| Boston Scientific Corporation | $21.60 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $18.46 | 2019 | |
| Abbvie INC. | $15.55 | 2023 | Botox |
| Therapeuticsmd, INC. | $14.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Duckett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.